```html

Gynecological Cancers (Ovarian & Uterine) – A Patient‑Friendly Guide

Overview

Gynecological cancers are malignancies that arise in a woman's reproductive organs. The two most common types are:

• Ovarian cancer – develops in the ovaries, the glands that produce eggs and hormones.
• Uterine (endometrial) cancer – begins in the lining of the uterus (the endometrium).

Both cancers mainly affect women after menopause, but they can occur at any age. According to the CDC and American Cancer Society:

• In the United States, ~21,750 new ovarian cancer cases and ~66,000 new uterine cancer cases are diagnosed each year.
• Uterine cancer is the 6th most common cancer among women worldwide, while ovarian cancer is the 8th.
• Overall 5‑year survival: ~49% for ovarian cancer (often diagnosed late) and ~81% for uterine cancer (usually caught early).

Symptoms

Early symptoms can be subtle, which is why awareness is crucial. Below is a comprehensive list; any persistent symptom lasting more than a few weeks should be discussed with a healthcare professional.

Ovarian Cancer

• Abdominal bloating or swelling – feeling of fullness even after small meals.
• Pelvic or lower‑abdominal pain – may be constant or intermittent.
• Changes in bowel habits – constipation, diarrhea, or a feeling of incomplete evacuation.
• Urgent or frequent urination – especially at night.
• Loss of appetite or early satiety – feeling full quickly.
• Unexplained weight loss – despite normal or reduced food intake.
• Back pain – dull ache that does not improve with rest.
• Menstrual changes – abnormal bleeding may occur in pre‑menopausal women.

Uterine (Endometrial) Cancer

• Abnormal vaginal bleeding – especially post‑menopause bleeding, spotting between periods, or unusually heavy periods.
• Pelvic pain or pressure – often described as a heaviness in the lower abdomen.
• Pain during intercourse (dyspareunia).
• Unexplained weight loss and fatigue.
• Fluid loss from the vagina – watery or mucous discharge.

Causes and Risk Factors

While the exact cause of most gynecological cancers is unknown, many factors increase risk.

Ovarian Cancer

• Age – risk rises sharply after age 50.
• Family history – BRCA1/BRCA2 gene mutations or Lynch syndrome.
• Reproductive history – never having been pregnant (nulliparity) or early menarche/late menopause.
• Hormone replacement therapy (HRT) – especially estrogen‑only regimens.
• Endometriosis – chronic pelvic inflammation is linked to certain ovarian cancers.
• Obesity – excess adipose tissue raises estrogen levels.

Uterine (Endometrial) Cancer

• Obesity – the strongest single risk factor; adipose tissue converts androgens to estrogen.
• Excess estrogen exposure – early menarche, late menopause, estrogen‑only HRT, or polycystic ovary syndrome (PCOS).
• Diabetes & hypertension – metabolic syndrome components increase risk.
• Family history – Lynch syndrome markedly raises risk.
• Nulliparity or never having breastfed.
• Prior radiation to the pelvis.

Diagnosis

Because symptoms overlap with benign conditions, a systematic work‑up is essential.

Initial Evaluation

• Medical history & pelvic exam – clinician assesses risk factors and looks for masses.
• Transvaginal ultrasound – first‑line imaging to visualize ovaries and uterine lining.
• Blood tests – CA‑125 (ovarian), HE4 (ovarian), and CBC & metabolic panel.

Further Imaging

• CT scan of abdomen & pelvis – evaluates spread (staging).
• MRI – useful for delineating uterine lesions.
• PET‑CT – detects distant metastases in advanced disease.

Definitive Diagnosis

• Biopsy – endometrial sampling (pipelle) for uterine cancer; for ovarian masses, laparoscopic or open surgical biopsy is standard.
• Pathology – determines cancer type (e.g., serous, mucinous ovarian; endometrioid, serous uterine) and grade.
• Molecular testing – BRCA, PTEN, KRAS, and mismatch‑repair (MMR) status guide targeted therapy.

Treatment Options

Treatment is personalized based on cancer type, stage, molecular profile, and patient health.

Ovarian Cancer

• Surgery – optimal cytoreductive (debulking) surgery removes as much tumor as possible; may include hysterectomy, bilateral salpingo‑oophorectomy, omentectomy, and lymph node sampling.
• Chemotherapy – platinum‑based regimens (carboplatin + paclitaxel) are standard; intraperitoneal chemo may be used in selected cases.
• Targeted therapy
  • PARP inhibitors (olaparib, niraparib) for BRCA‑mutated or HR‑deficient tumors.
  • Bevacizumab (anti‑VEGF) added to chemo for advanced disease.
• Hormonal therapy – for low‑grade serous tumors, aromatase inhibitors may be considered.
• Clinical trials – enrollment in trials offers access to emerging immunotherapies (e.g., pembrolizumab) and novel agents.

Uterine (Endometrial) Cancer

• Surgery – total hysterectomy with bilateral salpingo‑oophorectomy; sentinel‑lymph‑node mapping is increasingly used.
• Radiation therapy
  • External‑beam radiotherapy (EBRT) for high‑risk or advanced disease.
  • Vaginal brachytherapy to reduce local recurrence.
• Hormonal therapy – progestins (medroxyprogesterone) for grade 1 tumors in women who wish to preserve fertility.
• Chemotherapy – carboplatin + paclitaxel for stage III/IV or high‑grade tumors.
• Targeted therapy
  • Trastuzumab for HER2‑positive uterine serous carcinoma.
  • Immune checkpoint inhibitors (dostarlimab, pembrolizumab) for MSI‑high or dMMR tumors.

Lifestyle & Supportive Care

• Nutrition counseling – high‑protein, adequate calories to maintain weight.
• Physical therapy – gentle exercise improves fatigue and lymphedema risk.
• Psychosocial support – counseling, support groups, and survivorship programs.
• Fertility preservation – egg or embryo freezing before treatment for younger patients.

Living with Gynecological Cancers (e.g., Ovarian, Uterine)

Managing daily life after diagnosis involves physical, emotional, and practical strategies.

Managing Side Effects

• Fatigue – schedule short, frequent rest periods; prioritize sleep hygiene.
• Nausea – use prescribed anti‑emetics, eat small bland meals, stay hydrated.
• Peripheral neuropathy (common with taxanes) – wear supportive footwear, avoid extreme temperatures.
• Menopausal symptoms – consider non‑hormonal options like gabapentin for hot flashes; discuss HRT risks with your oncologist.

Practical Tips

• Keep a symptom diary to spot patterns and communicate effectively with your care team.
• Use a medication organizer to avoid missed doses.
• Arrange a **home health aide** or **family support** during periods of intense treatment.
• Plan **financial counseling** early; many hospitals have patient‑navigator programs.

Emotional Well‑Being

• Join a local or online support group (e.g., Cancer Support Community).
• Practice stress‑reduction techniques—mindfulness, guided imagery, or gentle yoga.
• Seek professional mental‑health care if you experience persistent sadness, anxiety, or thoughts of self‑harm.

Prevention

While not all cases are preventable, risk can be lowered through modifiable lifestyle choices.

• Maintain a healthy weight – Aim for BMI < 25; weight loss of even 5–10 % can reduce uterine cancer risk (NIH).
• Physical activity – ≥150 minutes of moderate aerobic exercise per week.
• Balanced diet – high in fruits, vegetables, whole grains; limit red meat and processed foods.
• Limit alcohol – no more than one drink per day.
• Avoid smoking – tobacco increases risk of several gynecologic cancers.
• Discuss hormone therapy – If HRT is needed, use the lowest effective dose for the shortest duration; consider combined estrogen‑progestin over estrogen‑only.
• Genetic counseling – Women with strong family histories should consider testing for BRCA, Lynch, and other hereditary syndromes; prophylactic surgery may be offered.
• Regular gynecologic care – Timely evaluation of abnormal bleeding or pelvic pain leads to earlier detection.

Complications

If left untreated or if disease progresses, several serious complications may arise.

• Ascites – fluid accumulation in the abdomen causing discomfort and breathing difficulty (common in advanced ovarian cancer).
• Intestinal obstruction – tumor invasion or adhesions block the bowel, leading to vomiting, abdominal pain, and inability to pass gas.
• Deep vein thrombosis (DVT) / Pulmonary embolism – malignancy creates a hypercoagulable state.
• Cachexia – severe weight loss and muscle wasting due to metabolic changes.
• Metastatic spread – to liver, lungs, brain, or bone, which can cause organ‑specific symptoms.
• Fistula formation – abnormal connections between the vagina and bladder or bowel after radiation.
• Secondary cancers – especially after certain chemotherapies or radiation.

When to Seek Emergency Care

References

• American Cancer Society. Ovarian Cancer Facts & Figures, 2024. Link
• CDC. Uterine (Endometrial) Cancer Statistics, 2023. Link
• Mayo Clinic. Ovarian Cancer Treatment Options, 2024. Link
• NIH National Cancer Institute. Endometrial Cancer Prevention, 2023. Link
• World Health Organization. Cancer Fact Sheets, 2022. Link
• Cleveland Clinic. Gynecologic Cancer Overview, 2024. Link

```